Perspective Therapeutics, Inc.
AMEX:CATX · New York Stock Exchange American
+$0.02 today
Vol 7.66M · Avg 1.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-28.22%
Period High
$5.65
Period Low
$2.05
Latest
$2.95
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$348.39M
Electromed, Inc.
AMEX:ELMD
$311.08M
Profound Medical Corp.
NASDAQ:PROF
$206.97M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$147.47M
Invivyd, Inc.
NASDAQ:IVVD
$129.62M
MaxCyte, Inc.
NASDAQ:MXCT
$125.87M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$119.35M
Solana Company
NASDAQ:HSDT
$94.29M
Neuronetics, Inc.
NASDAQ:STIM
$85.59M
Nyxoah S.A.
NASDAQ:NYXH
$60.60M
What is the latest CATX filing?
The latest filing shown is 8-K dated Jun 1, 2026.
How many recent filings does CATX have?
Intrinsic Alpha currently shows 20 recent filings for CATX.
Explore More
Continue the stock analysis
Jump to another research area for this company.